Professional Documents
Culture Documents
Testosterone Implants Benefits and Myths
Testosterone Implants Benefits and Myths
Testosterone Implants Benefits and Myths
Study (2)
"Among men with low testosterone levels and normal PSA,
testosterone treatment was not associated with an increased risk
of aggressive or any prostate cancer (CaP). The clinical risks and
benefits of testosterone treatment can only be fully addressed by
large, longer-term randomized controlled trials." [8]
Study (3)
"Despite the historical reluctance towards use of testosterone therapy
in men with a history of prostate cancer, modern evidence suggests
that testosterone replacement is a safe and effective treatment option
for hypogonadal men with non-high-risk prostate cancer." [9]
Study (4)
"The authors concluded that men with prostatic intraepithelial
neoplasia (PIN) do not have an increased risk of cancer development
when treated with testosterone replacement than men without PIN" [10]
Study (2)
"Similar conclusions were reached as a joint consensus between the
American Association of Clinical Endocrinologists and the American
College of Endocrinology in an official position paper that essentially
reports that no compelling evidence indicates that T therapy increases
CV risk" [13]
Reference: -
1) Medically reviewed by University of Illinois-Chicago, College
of Medicine on August 26, 2016 — Written by James Roland
https://www.healthline.com/health/what-is-testosterone
2) Medically reviewed by Daniel Murrell, MD on August 24, 2018
— Written by Christine Case-Lo
https://www.healthline.com/health/testosterone-pellets#talk-to-
your-doctor
3) A Review of Testosterone Pellets in the Treatment of
Hypogonadism Andrew McCullough 2014 Oct 3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431706/
4) Cavender RK, Fairall M. Subcutaneous testosterone pellet
implant (Testopel) therapy for men with testosterone deficiency
syndrome: a single-site retrospective safety analysis. J Sex Med.
2009;6(11):3177-92.
https://www.ncbi.nlm.nih.gov/pubmed/19796052
5) Kaminetsky JC, Moclair B, Hemani M, Sand M. A phase IV
prospective evaluation of the safety and efficacy of extended
release testosterone pellets for the treatment of male
hypogonadism. J Sex Med. 2011;8(4):1186-96.
https://www.ncbi.nlm.nih.gov/pubmed/21269402
6) Testosterone Pellet Therapy for Men by Paul Savage, MD,
FAARM, ABAARM August 29, 2016
https://www.power2practice.com/article/male-testosterone-
pellet-therapy/
7) Testosterone Replacement Therapy and Prostate Cancer
Incidence Michael Louis Eisenberg World J Mens Health. 2015
Dec; 33
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709428/
8) Testosterone treatment and the risk of aggressive prostate cancer
in men with low testosterone levels PLoS One. 2018; 13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014638/
9) Testosterone Therapy Among Prostate Cancer Survivors Sex
Med Rev. Author manuscript; 2017 Oct 1.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026903/
10) Testosterone replacement therapy and the risk of prostate cancer
Asian J Androl 2015 Apr 10
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814970/
11) Testosterone Therapy and Mortality Risk Int J Impot Res 2014
Jul 31 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312542/
12) Hackett GI. Testosterone Replacement Therapy and Mortality in
Older Men. Drug Saf. 2016;39(2):117-30.
https://www.ncbi.nlm.nih.gov/pubmed/26482385
13) Testosterone Replacement Therapy and Cardiovascular Risk: A
Review World J Mens Health 2015 Dec 23
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709429/